2022
DOI: 10.1007/s00423-022-02481-0
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative acute pancreatitis after pancreatic resection in patients with pancreatic ductal adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 27 publications
1
4
0
Order By: Relevance
“…Because of this discrepancy in PPAP definitions, it is difficult to compare results concerning the occurrence of this complication. Murakawa et al reported a 58.9% occurrence of postoperative pancreatitis after PD, applying Connor's definition of hyperamylasemia on POD0 and1 [20]. In our results, PPAP occurred in 38.5% of patients, with 18.2% of CR-PPAP.…”
Section: Discussionsupporting
confidence: 58%
“…Because of this discrepancy in PPAP definitions, it is difficult to compare results concerning the occurrence of this complication. Murakawa et al reported a 58.9% occurrence of postoperative pancreatitis after PD, applying Connor's definition of hyperamylasemia on POD0 and1 [20]. In our results, PPAP occurred in 38.5% of patients, with 18.2% of CR-PPAP.…”
Section: Discussionsupporting
confidence: 58%
“…In addition, it was noted that NAMPT may increase postoperatively due to the inflammatory changes and increased cellular metabolism, independent of the type of resection performed. In a significant proportion of patients who underwent pancreatic resection, inflammation has been found to play a critical role in the development of POPF [ 51 ]. It has been shown that inflammatory response reduces phosphate levels due to an increased metabolic state, increased cytokine release, inflammatory cell activation, and transcellular shifts, among other causes [ 29 , 50 , 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recent research has demonstrated the impact of systemic inflammatory factors and nutritional status on cancer prognosis [10]. Examples of such indicators include lymphocytes [11], monocytes [12], neutrophils [13], C-reactive protein (CRP) [14], and albumin levels (ALB) [15], To further improve the accuracy of cancer prognosis prediction, a combination of these biochemical indicators, such as the modified Glasgow Prognostic Score (mGPS) [16],C-reactive protein to albumin ratio [17],and neutrophil-to-lymphocyte ratio (NLR) [18], have been studied. A recent study analyzed the research hotspots in the field of immunonutrition and oncology over the past 25 years, exploring the potential of immunonutrition in cancer prevention, treatment, and improved outcomes [19].…”
Section: Introductionmentioning
confidence: 99%